世界の短腸症候群(SBS)治療薬市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20DC8475)
◆英語タイトル:Global Short Bowel Syndrome (SBS) Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20DC8475
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年12月(※2024年版があります。お問い合わせください。)
◆ページ数:103
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、短腸症候群(SBS)治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。短腸症候群(SBS)治療薬の種類別市場規模(グルカゴン様ペプチド-2(GLP-2)、成長ホルモン、グルタミン、その他)、用途別市場規模(病院、診療所、小売薬局)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Merck、Sancilio Pharmaceuticals、Ardelyx、Takeda、OxThera、Emmaus Medical、Nutrinia、Naia Pharmaceuticals、Zealand Pharma、
・地域別グローバル市場分析 2015年-2020年
・短腸症候群(SBS)治療薬の北米市場(アメリカ、カナダ、メキシコ)
・短腸症候群(SBS)治療薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・短腸症候群(SBS)治療薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・短腸症候群(SBS)治療薬の南米市場(ブラジル、アルゼンチン)
・短腸症候群(SBS)治療薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:グルカゴン様ペプチド-2(GLP-2)、成長ホルモン、グルタミン、その他
・用途別分析:病院、診療所、小売薬局
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Short Bowel Syndrome (SBS) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Short Bowel Syndrome (SBS) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Short Bowel Syndrome (SBS) Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Short Bowel Syndrome (SBS) Drugs market has been segmented into
Glucagon-Like Peptide-2 (GLP-2)
Growth Hormone
Glutamine
Other

By Application, Short Bowel Syndrome (SBS) Drugs has been segmented into:
Hospitals
Clinics
Retail Pharmacies

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Short Bowel Syndrome (SBS) Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Short Bowel Syndrome (SBS) Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Short Bowel Syndrome (SBS) Drugs market.

The report offers in-depth assessment of the growth and other aspects of the Short Bowel Syndrome (SBS) Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Short Bowel Syndrome (SBS) Drugs Market Share Analysis
Short Bowel Syndrome (SBS) Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Short Bowel Syndrome (SBS) Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Short Bowel Syndrome (SBS) Drugs sales, revenue and market share for each player covered in this report.

The major players covered in Short Bowel Syndrome (SBS) Drugs are:
Merck
Sancilio Pharmaceuticals
Ardelyx
Takeda
OxThera
Emmaus Medical
Nutrinia
Naia Pharmaceuticals
Zealand Pharma

Among other players domestic and global, Short Bowel Syndrome (SBS) Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Short Bowel Syndrome (SBS) Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Short Bowel Syndrome (SBS) Drugs, with price, sales, revenue and global market share of Short Bowel Syndrome (SBS) Drugs in 2018 and 2019.
Chapter 3, the Short Bowel Syndrome (SBS) Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Short Bowel Syndrome (SBS) Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Short Bowel Syndrome (SBS) Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Short Bowel Syndrome (SBS) Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Short Bowel Syndrome (SBS) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Short Bowel Syndrome (SBS) Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Glucagon-Like Peptide-2 (GLP-2)
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Short Bowel Syndrome (SBS) Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Overview of Global Short Bowel Syndrome (SBS) Drugs Market
1.4.1 Global Short Bowel Syndrome (SBS) Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sancilio Pharmaceuticals
2.2.1 Sancilio Pharmaceuticals Details
2.2.2 Sancilio Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sancilio Pharmaceuticals SWOT Analysis
2.2.4 Sancilio Pharmaceuticals Product and Services
2.2.5 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Ardelyx
2.3.1 Ardelyx Details
2.3.2 Ardelyx Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Ardelyx SWOT Analysis
2.3.4 Ardelyx Product and Services
2.3.5 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Takeda SWOT Analysis
2.4.4 Takeda Product and Services
2.4.5 Takeda Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 OxThera
2.5.1 OxThera Details
2.5.2 OxThera Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 OxThera SWOT Analysis
2.5.4 OxThera Product and Services
2.5.5 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Emmaus Medical
2.6.1 Emmaus Medical Details
2.6.2 Emmaus Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Emmaus Medical SWOT Analysis
2.6.4 Emmaus Medical Product and Services
2.6.5 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Nutrinia
2.7.1 Nutrinia Details
2.7.2 Nutrinia Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Nutrinia SWOT Analysis
2.7.4 Nutrinia Product and Services
2.7.5 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Naia Pharmaceuticals
2.8.1 Naia Pharmaceuticals Details
2.8.2 Naia Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Naia Pharmaceuticals SWOT Analysis
2.8.4 Naia Pharmaceuticals Product and Services
2.8.5 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Zealand Pharma
2.9.1 Zealand Pharma Details
2.9.2 Zealand Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Zealand Pharma SWOT Analysis
2.9.4 Zealand Pharma Product and Services
2.9.5 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Short Bowel Syndrome (SBS) Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Short Bowel Syndrome (SBS) Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
4.5 South America Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
6.3 UK Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
6.4 France Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7.5 India Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Short Bowel Syndrome (SBS) Drugs Price by Type (2015-2020)
11 Global Short Bowel Syndrome (SBS) Drugs Market Segment by Application
11.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2015-2020)
11.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Short Bowel Syndrome (SBS) Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Short Bowel Syndrome (SBS) Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025)
12.2.2 Europe Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025)
12.2.4 South America Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025)
12.3 Short Bowel Syndrome (SBS) Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Type (2021-2025)
12.4 Short Bowel Syndrome (SBS) Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【掲載企業】

Merck、Sancilio Pharmaceuticals、Ardelyx、Takeda、OxThera、Emmaus Medical、Nutrinia、Naia Pharmaceuticals、Zealand Pharma、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の短腸症候群(SBS)治療薬市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Short Bowel Syndrome (SBS) Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。